News / Events

On March 1st, 2014, ActeaVentures GmbH (Karlsruhe, Germany) entered into an agreement with Xplico ApS (Copenhagen, Denmark) in which both companies will collaborate on selected projects in the areas of forecasting and project valuation.

“We are very pleased being able to offer our clients nowadays most advanced and validated option for forecasting and project valuation in the Life Sciences industry”, says Jörg Landwehr, one of ActeaVentures’ Managing Partners. “The Xplico Evaluator has proven to be an excellent tool for the modelling of licensing scenarios and can be very well used to guide the negotiation of deal terms which is part of our service offer to clients in Pharma, Biotech, Diagnostics and MedTech.”

Uffe Boesen, Partner at Xplico ApS, commented, “We are pleased about this collaboration with ActeaVentures as both companies serve the same spectrum of clients. Our valuation tool and expertise can provide additional benefit to ActeaVentures’ clients when it comes to negotiating deal terms for which it is mandatory to being fully aware of the value of the respective licensing project and the impact of all deal parameters on the value distribution between licensor and licensee.”

About Xplico Evaluator

Xplico Evaluator converts Microsoft Excel into an easy-to-use, flexible valuation tool with integrated risk assessment and powerful analysis features for the life science industry. It has been developed and is provided by Xplico ApS ( , based in Copenhagen, Denmark.

About ActeaVentures

ActeaVentures is a global business development advisory firm for the Life Sciences Industry with operations in Europe, Asia and the US. With offices in Berlin, Karlsruhe, Lyon, Madrid, San Francisco, Shanghai and Singapore, ActeaVentures offers its clients comprehensive services for licensing and M&A projects in Pharma, Biotech, Diagnostics and Medtech. ActeaVentures’ team consists of Senior Business Development professionals with strong track records in dealmaking, having successfully served big pharma, medium-sized and biotech companies. ActeaVenturs GmbH ( is privately held and registered in Karlsruhe, Germany.